BACKGROUND: Schistosomiasis increases the risk of human immunodeficiency virus (HIV) acquisition in women by mechanisms that are incompletely defined. Our objective was to determine how the cervical environment is impacted by Schistosoma haematobium or Schistosoma mansoni infection by quantifying gene expression in the cervical mucosa and cytokine levels in cervicovaginal lavage fluid. METHODS: We recruited women with and those without S. haematobium infection and women with and those without S. mansoni infection from separate villages in rural Tanzania with high prevalences of S. haematobium and S. mansoni, respectively. Infection status was determined by urine and stool microscopy and testing for serum circulating anodic antigen. RNA was extracted from cervical cytobrush samples for transcriptome analysis. Cytokine levels were measured by magnetic bead immunoassay. RESULTS: In the village where S. haematobium was prevalent, 110 genes were differentially expressed in the cervical mucosa of 18 women with versus 39 without S. haematobium infection. Among the 27 cytokines analyzed in cervicovaginal lavage fluid from women in this village, the level of interleukin 15 was lower in the S. haematobium-infected group (62.8 vs 102.9 pg/mL; adjusted P = .0013). Differences were not observed in the S. mansoni-prevalent villages between 11 women with and 29 without S. mansoni infection. CONCLUSIONS: We demonstrate altered cervical mucosal gene expression and lower interleukin 15 levels in women with S. haematobium infection as compared to those with S. mansoni infection, which may influence HIV acquisition and cancer risks. Studies to determine the effects of antischistosome treatment on these mucosal alterations are needed.
BACKGROUND: Schistosomiasis increases the risk of human immunodeficiency virus (HIV) acquisition in women by mechanisms that are incompletely defined. Our objective was to determine how the cervical environment is impacted by Schistosoma haematobium or Schistosoma mansoni infection by quantifying gene expression in the cervical mucosa and cytokine levels in cervicovaginal lavage fluid. METHODS: We recruited women with and those without S. haematobium infection and women with and those without S. mansoni infection from separate villages in rural Tanzania with high prevalences of S. haematobium and S. mansoni, respectively. Infection status was determined by urine and stool microscopy and testing for serum circulating anodic antigen. RNA was extracted from cervical cytobrush samples for transcriptome analysis. Cytokine levels were measured by magnetic bead immunoassay. RESULTS: In the village where S. haematobium was prevalent, 110 genes were differentially expressed in the cervical mucosa of 18 women with versus 39 without S. haematobium infection. Among the 27 cytokines analyzed in cervicovaginal lavage fluid from women in this village, the level of interleukin 15 was lower in the S. haematobium-infected group (62.8 vs 102.9 pg/mL; adjusted P = .0013). Differences were not observed in the S. mansoni-prevalent villages between 11 women with and 29 without S. mansoni infection. CONCLUSIONS: We demonstrate altered cervical mucosal gene expression and lower interleukin 15 levels in women with S. haematobium infection as compared to those with S. mansoni infection, which may influence HIV acquisition and cancer risks. Studies to determine the effects of antischistosome treatment on these mucosal alterations are needed.
Authors: Eyrun Floerecke Kjetland; Patricia D Ndhlovu; Takafira Mduluza; Exenevia Gomo; Lovemore Gwanzura; Peter R Mason; Edith Nyaradzai Kurewa; Nicholas Midzi; Henrik Friis; Svein Gunnar Gundersen Journal: Am J Trop Med Hyg Date: 2005-03 Impact factor: 2.345
Authors: Eyrun F Kjetland; Patricia D Ndhlovu; Exenevia Gomo; Takafira Mduluza; Nicholas Midzi; Lovemore Gwanzura; Peter R Mason; Leiv Sandvik; Henrik Friis; Svein Gunnar Gundersen Journal: AIDS Date: 2006-02-28 Impact factor: 4.177
Authors: Adriana C Vidal; David Skaar; Rachel Maguire; Seyram Dodor; Laura W Musselwhite; John A Bartlett; Olola Oneko; Joseph Obure; Pendo Mlay; Susan K Murphy; Cathrine Hoyo Journal: Infect Agent Cancer Date: 2015-03-20 Impact factor: 2.965
Authors: Jennifer A Downs; Kathryn M Dupnik; Govert J van Dam; Mark Urassa; Peter Lutonja; Dieuwke Kornelis; Claudia J de Dood; Pytsje Hoekstra; Chifundo Kanjala; Raphael Isingo; Robert N Peck; Myung Hee Lee; Paul L A M Corstjens; Jim Todd; John M Changalucha; Warren D Johnson; Daniel W Fitzgerald Journal: PLoS Negl Trop Dis Date: 2017-09-25
Authors: Brooke W Bullington; Myung Hee Lee; Jane Mlingi; Ndalloh Paul; Christine Aristide; Emily Fontana; Eric R Littmann; Crispin Mukerebe; Peter Shigella; Philibert Kashangaki; Samuel E Kalluvya; Claudia J de Dood; Govert J van Dam; Paul L A M Corstjens; Daniel W Fitzgerald; Eric G Pamer; Jennifer A Downs Journal: ISME J Date: 2021-01-06 Impact factor: 10.302
Authors: Sergey Yegorov; Vineet Joag; Ronald M Galiwango; Sara V Good; Juliet Mpendo; Egbert Tannich; Andrea K Boggild; Noah Kiwanuka; Bernard S Bagaya; Rupert Kaul Journal: Nat Commun Date: 2019-05-24 Impact factor: 14.919
Authors: Amy S Sturt; Emily L Webb; Catriona Patterson; Comfort R Phiri; Tobias Mweene; Eyrun F Kjetland; Maina Mudenda; Joyce Mapani; Mable M Mutengo; James Chipeta; Govert J van Dam; Paul L A M Corstjens; Helen Ayles; Richard J Hayes; Isaiah Hansingo; Piet Cools; Lisette van Lieshout; Helena Helmby; Grace A McComsey; Suzanna C Francis; Amaya L Bustinduy Journal: Front Immunol Date: 2021-03-02 Impact factor: 7.561
Authors: Sergey Yegorov; Vineet Joag; Ronald M Galiwango; Sara V Good; Brenda Okech; Rupert Kaul Journal: Trop Dis Travel Med Vaccines Date: 2019-11-29
Authors: Dirk Engels; Peter J Hotez; Camilla Ducker; Margaret Gyapong; Amaya L Bustinduy; William E Secor; Wendy Harrison; Sally Theobald; Rachael Thomson; Victoria Gamba; Makia C Masong; Patrick Lammie; Kreeneshni Govender; Pamela S Mbabazi; Mwelecele N Malecela Journal: Bull World Health Organ Date: 2020-07-06 Impact factor: 9.408